0001209191-22-031402.txt : 20220523 0001209191-22-031402.hdr.sgml : 20220523 20220523175312 ACCESSION NUMBER: 0001209191-22-031402 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220523 FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenway Schond L. CENTRAL INDEX KEY: 0001848205 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40360 FILM NUMBER: 22953091 MAIL ADDRESS: STREET 1: C/O CERECOR, INC. STREET 2: 540 GAITHER ROAD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc. CENTRAL INDEX KEY: 0001813814 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 BUSINESS PHONE: (212) 220-6633 MAIL ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-23 0 0001813814 Mind Medicine (MindMed) Inc. MNMD 0001848205 Greenway Schond L. C/O MIND MEDICINE (MINDMED), INC. ONE WORLD TRADE CENTER, SUITE 8500 NEW YORK NY 10007 0 1 0 0 Chief Financial Officer Subordinate Voting Shares 2022-05-23 4 A 0 1270000 0.00 A 1270000 D Stock Option (Right to Buy) 0.71 2022-05-23 4 A 0 1650000 0.00 A 2027-05-22 Subordinate Voting Shares 1650000 1650000 D These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on May 23, 2023 with 1/12th of the remaining shares vesting each quarter thereafter over 12 quarters, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date. The option grant has an exercise price of $0.91 Canadian Dollars. This represents the exercise price in United States Dollars. The shares subject to the option vest and become exercisable, with 25% vesting on May 23, 2023, and 1/36th of the remaining shares vesting monthly thereafter over 36 months, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date. /s/ Schond L. Greenway 2022-05-23